Statements of Shareholders' Deficiency - USD ($)	12 Months Ended
	Jan. 31, 2018	Jan. 31, 2017
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balances	$ (482,558)	$ (393,899)
Net loss	(87,147)	(88,659)
Ending balances	$ (569,705)	$ (482,558)
Common Stock
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Shares, beginning balance (in shares)	1,899,575	1,899,575
Beginning balances	$ 1,900	$ 1,900
Shares, ending balance (in shares)	1,899,575	1,899,575
Ending balances	$ 1,900	$ 1,900
Additional Paid-in Capital
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balances	8,418,684	8,418,684
Ending balances	8,418,684	8,418,684
Accumulated Deficit
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balances	(8,903,142)	(8,814,483)
Net loss	(87,147)	(88,659)
Ending balances	$ (8,990,289)	$ (8,903,142)